Navigation Links
Channel Medsystems Receives Health Canada Approval to Begin Clinical Evaluation of its Innovative Procedure for Heavy Menstrual Bleeding; Hires Mary Edwards as Senior Vice President, Clinical and Regulatory Affairs.
Date:11/11/2013

well-tolerated under minimal anesthesia.  We believe our innovative delivery of cryothermic energy provides an excellent platform to treat heavy menstrual bleeding and we are excited to validate this application in our CRYSTAL clinical trial. Ultimately, we believe our technology will accelerate the transition of GEA procedures into the office setting, which in turn should translate into significant cost reductions for the healthcare system," said Ric Cote, President and CEO of Channel Medsystems.

Channel Medsystems also announced it has hired Mary Edwards, one of the top clinical and regulatory experts in the field of women's health, to run its North American trial and to serve as the Company's Senior Vice President of Clinical and Regulatory Affairs.  "Throughout my career, I have been a passionate advocate for technologies and procedures that benefit women," said Ms. Edwards.  "Our technology couples the gentle and safe profile of cryothermic energy with an intelligent system that supports precision and ease of use.  I am excited to be in a position where I can help bring a much-needed innovation to women suffering with heavy menstrual bleeding."

About the Cryothermic Technology Platform: Channel Medsystems' novel cryothermic technology and streamlined delivery system were developed with feedback from leading clinicians and biomedical engineers at the healthcare incubator, Theranova. The technology integrates cryothermic energy and the user controls into a self-contained, hand held device, eliminating the need for a separate control unit or capital equipment. 

About Channel Medsystems:  Channel Medsystems is a venture-backed company that was founded to bring innovation to the delivery of women's healthcare. The Company strives to develop treatments to meet the unique needs of female patients and the high standards of their healthcare providers. Channel M
'/>"/>

SOURCE Channel Medsystems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SoundConnect Launches Innovative Channel Partner Webinar Series
2. ReachMD Radio Joins Clear Channel’s iHeartRadio
3. Multichannel Pipettes Promotion Now Available at Pipette.com
4. Discovery Channel MythBuster Star Jaime Vendera First Person on Record to Break a Glass with His Voice Endorses UV-Aid by UV Technologies, LLC
5. New from Cole-Parmer: Ismatec Reglo Independent Channel Control Peristaltic Pump
6. SoundConnect Named Adobe Connect Channel Partner
7. YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group
8. ReachMD on XM Satellite Radio Moves to Channel 245 Effective May 9, 2013
9. ChanTest Introduces the CardioChannelGram™ and SaVety Assessment
10. NSG Announces New Quartz Micro Flow Channel
11. Amarantus Bioscience Launches Online Corporate Communication Channels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Theravalues Corporation est fier d,annoncer le ... au salon Hi Europe 2014 (du 2 au ... Curcumine la plus biodisponible actuellement sur le ... des ingrédients approuvés par les règlements européens. ... dans la racine de curcuma ( Curcuma longa ...
(Date:11/26/2014)... , 25 novembre 2014 /PRNewswrie/ -- Theravalues Corporation ... il mercato europeo in occasione di Hi Europe 2014 ... ). Si tratta della curcumina con la ... amorfa (senza cristalli) e ingredienti approvati dalle norme europee. ... nella spezia della pianta curcumina ( Curcuma longa ) ...
(Date:11/24/2014)... 24, 2014  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has submitted an ... Food and Drug Administration (FDA), which brings the Company,s ... with eighteen submissions now pending at the FDA. ... of the Company, commented, "Our team here at IGI ...
(Date:11/24/2014)... Nov. 24, 2014  Last week, Representatives ... (D-NC) took a bold bipartisan step on ... the OPEN Act. Original co-sponsors of the legislation ... Act will incentivize drug makers and innovators to ... and pediatric cancers, which opens the door to ...
Breaking Biology Technology:La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3IGI Laboratories, Inc. Announces ANDA Submission 2OPEN Act Introduced to Repurpose Drugs for Rare Diseases 2
... Duke University bioengineers have not only figured out a ... cells, they can now slip them into the command center ... report back important information or drop off payloads. Using ... that has an uncanny ability to penetrate human cells, ...
... 28 /PRNewswire-FirstCall/ - Neuro-Biotech Corporation (PINKSHEETS: MRES) (OTCQB: MRES) ... 1 SymPath(R) TO EVALUATE THE ... (DBH), THAT IS RELEASED WITH NORADRENALINE WITHIN THE BLOOD ... NEURO # 2 AXIS(TM) ...
... Sept. 28 /PRNewswire-Asia-FirstCall/ -- ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for ...
Cached Biology Technology:Sneaking spies into a cell's nucleus 2Sneaking spies into a cell's nucleus 3NEURO-BIOTECH DISCLOSES ITS LIST OF LICENSES 2Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 2Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 3Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 4Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 5Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 6Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 7Tongjitang Chinese Medicines Company Enters into Share Transfer Agreement 8
(Date:11/7/2014)... -- Leading Biometric companies aim to provide consumers ... transactions.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... ), Google Inc. (NASDAQ: GOOG ), Microsoft Corporation ... EBAY ) and MasterCard Inc. (NYSE: MA) NXT-ID, ... authentication company focused on the growing mobile commerce is pleased ...
(Date:11/6/2014)... cancer deaths occur because of metastasis, yet progress ... been slow. , "It,s been particularly challenging to ... Gujral, research fellow in systems biology at Harvard ... detected until after they,ve already metastasized." , Gujral ... that should help researchers better understand how metastasis ...
(Date:11/6/2014)... Medicine, Inc, a Baltimore-based bioinformatics company focused on ... a research collaboration with the international leader in ... CSBR). , "There are many companies utilizing advances ... TumorGraft technology is unique in a way that ... vast amounts of valuable data. Our bioinformatic analysis ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Migration negation 2Migration negation 3Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2
... with backache caused by nerve root pain ?commonly known ... if therapeutic ultrasound can help their condition. , Dr ... for Rehabilitation Science need 30 volunteers aged 22-55 who ... not pregnant and have not had previous spinal surgery. ...
... in high tech tools, researchers have identified three proteins ... to 20 months before the rejection occurred. , Lung ... recipients, about 45% over five years, said lead investigator ... way to predict which transplants will fail, and when ...
... the survival of many types of cells stimulates rapid ... connect the cerebral cortex with the spinal cord and ... sclerosis (ALS or Lou Gehrig's disease). In the ... Massachusetts General Hospital (MGH) and the Harvard Stem Cell ...
Cached Biology News:Proteins may predict lung transplant rejection 2Proteins may predict lung transplant rejection 3Growth factor stimulates rapid extension of key motor neurons in brain 2